Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jan 13, 2026 3:57:30 PM EST

8.59USD+0.584%(+0.05)15,387

7.80Bid 8.78Ask 0.98Spread

Pre-market

Jan 14, 2026 9:20:30 AM EST

8.01USD-6.206%(-0.53)282

After-hours

Jan 12, 2026 4:51:30 PM EST

7.84USD-0.758%(-0.06)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

8.11M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

276,039

Avg. Vol. 30 Day

102,375

Employees

Market Cap

8,110,582

Shares Out.

916,968

On/Off Exchange

64%/36%

6 Month Beta

0.21

1 Year Beta

0.58

2 Year Beta

0.77

3 Year Beta

-0.13

52 Week Low

6.08

52 Week High

468.44

SMA50

8.61

SMA200

9.95

1 Week

+18.41%

1 Month

-2.48%

3 Month

-38.06%

6 Month

-2.91%

1 Year

-90.60%

2 Year

-99.75%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $8.59, and today's volume is 15,387. RNAZ is up 0.584% today. The 30 day average volume is 102,375. RNAZ market cap is 8.11M with 916,968 shares outstanding.

.dark-mode .CCr7D1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .CCr7D1{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ